Chapter 5 154 15. Clark MR, Katon W, Russo J, Kith P, Sintay M, Buchwald D. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med. 1995;98(2):187-95. doi:10.1016/ S0002-9343(99)80403-3 16. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM. 1997;90(3):223-33. doi:10.1093/qjmed/90.3.223 17. Wynberg E, van Willigen HDG, Dijkstra M, Boyd A, Kootstra NA, van den Aardweg JG, et al. Evolution of COVID-19 symptoms during the first 12 months after illness onset. Clin Infect Dis. 2021. doi:10.1093/cid/ciab759 18. GeurtsvanKessel CH, Okba NMA, Igloi Z, Bogers S, Embregts CWE, Laksono BM, et al. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020;11(1):3436. doi:10.1038/s41467-020-17317-y 19. ISARIC. Clinical Data Collection – The COVID-19 Case Report Forms (CRFs) [ 20. Alberts M, Smets EM, Vercoulen JH, Garssen B, Bleijenberg G. [‘Abbreviated fatigue questionnaire’: a practical tool in the classification of fatigue]. Ned Tijdschr Geneeskd. 1997;141(31):1526-30. 21. Penson A, van Deuren S, Worm-Smeitink M, Bronkhorst E, van den Hoogen FHJ, van Engelen BGM, et al. Short fatigue questionnaire: Screening for severe fatigue. J Psychosom Res. 2020;137:110229. doi:10.1016/j.jpsychores.2020.110229 22. World Health Organization. COVID-19 Clinical management: living guidance. 2021 25 January 2021. 23. Stronks K, Kulu-Glasgow I, Agyemang C. The utility of ‘country of birth’ for the classification of ethnic groups in health research: the Dutch experience. Ethnic Health. 2009;14(3):255-69. doi:10.1080/13557850802509206 24. Centraal Bureau voor de Statistiek. Migratieachtergrond. [Available from: https://www.cbs.nl/ nl-nl/onze-diensten/methoden/begrippen/migratieachtergrond. 25. OECD. DAC List of ODA Recipients 2021 [Available from: https://www.oecd.org/dac/financingsustainable-development/development-finance-standards/daclist.htm. 26. Goertz YMJ, Braamse AMJ, Spruit MA, Janssen DJA, Ebadi Z, Van Herck M, et al. Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Sci Rep. 2021;11(1):20977. doi:10.1038/s41598-021-00337-z 27. Peiris S, Mesa H, Aysola A, Manivel J, Toledo J, Borges-Sa M, et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS One. 2021;16(4):e0250708. doi:10.1371/journal.pone.0250708 28. Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021;9(6):622-42. doi:10.1016/S2213-2600(21)00218-6 29. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416-27. doi:10.1016/S2215-0366(21)00084-5 30. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. doi:10.1016/S01406736(20)32656-8 31. Arnett SV, Alleva LM, Korossy-Horwood R, Clark IA. Chronic fatigue syndrome- -a neuroimmunological model. Med Hypotheses. 2011;77(1):77-83. doi:10.1016/j. mehy.2011.03.030
RkJQdWJsaXNoZXIy MTk4NDMw